Diabetic ketoacidosis (DKA) acute management
DKA management is based on simultaneous correction of fluid deficit, insulin deficiency, and electrolyte abnormalities, with monitoring until ketoacidosis resolution using a physiologic endpoint (anion gap closure and improvement in pH/bicarbonate). [1]
DKA is managed in an emergency/critical care setting with frequent laboratory reassessment. [1]
Immediate assessment and stabilization steps
- Confirm diagnosis and assess severity
- Obtain point-of-care glucose, basic metabolic panel, serum/venous blood gas, and calculate the anion gap. [1]
-
Evaluate for precipitating causes (infection, missed insulin, myocardial infarction, stroke, pancreatitis, other acute stressors). [1]
-
Start continuous monitoring
-
Continuous vital sign and neurologic monitoring is recommended due to risk for rapid physiologic change. [1]
-
Start fluids promptly
- Isotonic crystalloid is recommended as first-line fluid resuscitation. [1]
Fluid resuscitation strategy
- Use isotonic fluids initially
-
Initial fluid therapy should be isotonic crystalloid, with subsequent adjustments based on blood pressure, perfusion, sodium status, and hemodynamics. [1]
-
Add dextrose when glucose falls despite ongoing ketoacidosis treatment
-
Dextrose should be added to intravenous fluids to permit continued insulin infusion once serum glucose approaches the target range used in the protocol. [1]
-
Avoid overcorrection of fluids/electrolytes
- Frequent reassessment of electrolytes and volume status is recommended due to the risk of worsening electrolyte derangements during treatment. [1]
Insulin therapy algorithm
- Confirm potassium is safe before starting insulin
-
Insulin should not be started until serum potassium is at least the threshold required for safe therapy because insulin will drive potassium intracellularly. [2]
-
Start insulin infusion
-
Continuous intravenous insulin infusion at a fixed starting rate (commonly 0.1 units/kg/h) is recommended in many protocols for adults. [1]
-
Adjust insulin infusion based on glucose and ketoacidosis markers
-
Insulin infusion should be adjusted to maintain glucose at approximately 200 mg/dL and continued until ketoacidosis resolves. [1]
-
Continue insulin until resolution of ketoacidosis
- Insulin infusion should not be stopped when hyperglycemia improves if ketoacidosis persists. [2]
Potassium and other electrolyte replacement steps
- Treat potassium based on measured serum level
- Potassium replacement is required because total body potassium is depleted despite initial serum hyperkalemia. [1]
-
During insulin therapy, serum potassium typically falls and requires ongoing monitoring. [1]
-
Monitoring frequency for electrolytes
-
Electrolytes and blood gas parameters should be monitored frequently during therapy to guide potassium replacement and insulin adjustments. [1]
-
Bicarbonate is not routine
- Bicarbonate is generally reserved for severe acidemia due to lack of routine benefit and potential harms; severity-based triggers are used in practice guidelines/protocols. [3]
Stepwise monitoring and criteria for stopping DKA treatment
- Monitor response using a structured schedule
-
Venous blood gas/pH, bicarbonate, and anion gap are used to track resolution. The Management of Diabetic Ketoacidosis in Adults (JBDS pathway, 2023)
-
DKA resolution endpoint
-
DKA is considered resolved when ketoacidosis has improved on physiologic markers used in protocols (eg, venous pH improving and anion gap closure) and insulin/glucose management can transition. The Management of Diabetic Ketoacidosis in Adults (JBDS pathway, 2023)
-
Transition from IV insulin to subcutaneous insulin
- Subcutaneous insulin should be started with overlap timing per protocol to prevent rebound ketosis once IV insulin is discontinued. The Management of Diabetic Ketoacidosis in Adults (JBDS pathway, 2023)
Common pitfalls to avoid
- Starting insulin when potassium is too low
-
Insulin can precipitate or worsen hypokalemia by shifting potassium intracellularly, so potassium must meet the protocol threshold before insulin initiation. [2]
-
Stopping insulin based on glucose alone
-
Improvement in serum glucose does not reliably indicate ketoacidosis resolution, so insulin should continue until ketoacidosis resolves on physiologic criteria. [2]
-
Inadequate laboratory reassessment
- Frequent electrolyte and acid-base monitoring is required due to rapid treatment-associated shifts. [1]
Special populations and differential considerations
- Mixed DKA/HHS physiology and atypical presentations
-
Hyperglycemic crises require assessment for HHS overlap and other causes of acidosis. [1]
-
Euglycemic DKA
- Euglycemic presentations require the same physiologic principles (insulin, fluids, potassium, and ketoacidosis monitoring) despite lower glucose. [2]